Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if VRCA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
9 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 58 days ago
Red flags: 1
43 filers reported a long position in VRCA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Caligan Partners LP | $5.7M | 923.9K | Unchanged |
| CANNELL CAPITAL LLC | $4.8M | 783.9K | +14.4% |
| Affinity Asset Advisors, LLC | $4.3M | 707.3K | Unchanged |
| Velan Capital Investment Management LP | $2.9M | 471.6K | Unchanged |
| ARMISTICE CAPITAL, LLC | $2.6M | 426.3K | -17.7% |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.7M | 280.7K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.7M | 279.3K | +48% |
| Mariner, LLC | $1.3M | 207.2K | +744.3% |
| GEODE CAPITAL MANAGEMENT, LLC | $845.7K | 138.2K | -0.5% |
| BlackRock, Inc. | $455K | 74.3K | +92.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.